Identification of microRNA hsa-miR-30c-5p as an inhibitory factor in the progression of hepatocellular carcinoma and investigation of its regulatory network via comprehensive analysis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Xu W, Liu K, Chen M, et al. Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives. Ther Adv Med Oncol. 2019;11:1758835919862692.
   Web of Science ®Google Scholar
• Wang L, Ge S, Zhou F. MicroRNA-487a-3p inhibits the growth and invasiveness of oral squamous cell carcinoma by targeting PPM1A. Bioengineered. 2021;12(1):937–947.
   PubMed Web of Science ®Google Scholar
• Liao Z, Zhang H, Su C, et al. Long noncoding RNA SNHG14 promotes hepatocellular carcinoma progression by regulating miR-876-5p/SSR2 axis. J Exp Clin Cancer Res. 2021;40(1):36.
   PubMed Web of Science ®Google Scholar
• Shin Low S, Pan Y, Ji D, et al. Smartphone-based portable electrochemical biosensing system for detection of circulating microRNA-21 in saliva as a proof-of-concept. Sens Actuators B Chem. 2020;308:127718.
   Web of Science ®Google Scholar
• Prasad KS, Cao X, Gao N, et al. A low-cost nanomaterial-based electrochemical immunosensor on paper for high-sensitivity early detection of pancreatic cancer. Sens Actuators B Chem. 2020;305:127516.
   PubMed Web of Science ®Google Scholar
• Long J, Bai Y, Yang X, et al. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma. Cancer Cell Int. 2019;19(1):90.
   PubMed Web of Science ®Google Scholar
• Wang Y, Pei X, Xu P, et al. E2F7, regulated by miR‑30c, inhibits apoptosis and promotes cell cycle of prostate cancer cells. Oncol Rep. 2020;44(3):849–862.
   PubMed Web of Science ®Google Scholar
• Han W, Mu Y, Zhang Z, et al. Expression of miR-30c and BCL-9 in gastric carcinoma tissues and their function in the development of gastric cancer. Oncol Lett. 2018;16(2):2416–2426.
   PubMed Web of Science ®Google Scholar
• Yuan RX, Bao D, Zhang Y. Linc00707 promotes cell proliferation, invasion, and migration via the miR-30c/CTHRC1 regulatory loop in breast cancer. Eur Rev Med Pharmacol Sci. 2020;24(9):4863–4872.
   PubMed Web of Science ®Google Scholar
• Xue C, Cheng Y, Wu J, et al. Circular RNA CircPRMT5 accelerates proliferation and invasion of papillary thyroid cancer through regulation of miR-30c/E2F3 axis. Cancer Manag Res. 2020;12:3285–3291.
   PubMed Web of Science ®Google Scholar
• Liu S, Li X, Zhuang S. miR-30c Impedes glioblastoma cell proliferation and migration by targeting SOX9. Oncol Res. 2019;27(2):165–171.
   PubMed Web of Science ®Google Scholar
• Menyhárt O, Nagy Á, Győrffy B. Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc Open Sci. 2018;5(12):181006.
   PubMed Web of Science ®Google Scholar
• Chang L, Zhou G, Soufan O, et al. miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 2020;48(W1):W244–w251.
   PubMed Web of Science ®Google Scholar
• Paraskevopoulou MD, Georgakilas G, Kostoulas N, et al. DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res. 2013;41( WebServer issue):W169–173.
   PubMed Web of Science ®Google Scholar
• Shin C, Nam JW, Farh KK, et al. Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell. 2010;38(6):789–802.
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam JW, et al. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015,Aug 12;4:e05005. doi: 10.7554/eLife.05005. PMID: 26267216; PMCID: PMC4532895.
   Web of Science ®Google Scholar
• Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127–d131.
   PubMed Web of Science ®Google Scholar
• Xu G, Xu WY, Xiao Y, et al. The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma. Cancer Cell Int. 2020;20(1):496.
   PubMed Web of Science ®Google Scholar
• Liu D, Wu J, Liu M, et al. Downregulation of miRNA-30c and miR-203a is associated with hepatitis C virus core protein-induced epithelial-mesenchymal transition in normal hepatocytes and hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2015;464(4):1215–1221.
   PubMed Web of Science ®Google Scholar
• Oksuz Z, Serin MS, Kaplan E, et al. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. Mol Biol Rep. 2015;42(3):713–720.
   PubMed Web of Science ®Google Scholar
• Wu W, Zhang X, Liao Y, et al. miR-30c negatively regulates the migration and invasion by targeting the immediate early response protein 2 in SMMC-7721 and HepG2 cells. Am J Cancer Res. 2015;5(4):1435–1446.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang X, Wang Y, et al. Low expression of microRNA-30c promotes prostate cancer cells invasion involved in downregulation of KRAS protein. Oncol Lett. 2017;14(1):363–368.
   PubMed Web of Science ®Google Scholar
• Huang YQ, Ling XH, Yuan RQ, et al. miR30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein. Mol Med Rep. 2017;16(3):2431–2438.
   PubMed Web of Science ®Google Scholar
• Tanic M, Yanowsky K, Rodriguez-Antona C, et al. Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene. PLoS One. 2012;7(6):e38847.
   PubMed Web of Science ®Google Scholar
• Liang Z, Feng A, Shim H. MicroRNA-30c-regulated HDAC9 mediates chemoresistance of breast cancer. Cancer Chemother Pharmacol. 2020;85(2):413–423.
   PubMed Web of Science ®Google Scholar
• Pei B, Li T, Qian Q, et al. Downregulation of microRNA-30c-5p was responsible for cell migration and tumor metastasis via COTL1-mediated microfilament arrangement in breast cancer. Gland Surg. 2020;9(3):747–758.
   PubMed Web of Science ®Google Scholar
• Sun LL, Cheng M, Xu XD. MicroRNA-30c inhibits pancreatic cancer cell proliferation by targeting twinfilin 1 and indicates a poor prognosis. World J Gastroenterol. 2019;25(42):6311–6321.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Okada R, Hozaka Y, et al. Molecular pathogenesis of pancreatic ductal adenocarcinoma: impact of miR-30c-5p and miR-30c-2-3p regulation on oncogenic genes. Cancers (Basel). 2020;12(10):10.
   Web of Science ®Google Scholar
• Wong VC, Wong MI, Lam CT, et al. Hallmark microRNA signature in liquid biopsy identifies hepatocellular carcinoma and differentiates it from liver metastasis. J Cancer. 2021;12(15):4585–4594.
   PubMed Web of Science ®Google Scholar
• Song S, Long M, Yu G, et al. Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5. J Cell Mol Med. 2019;23(10):6755–6765.
   PubMed Web of Science ®Google Scholar
• Xie X, Xu X, Sun C, et al. Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma. Exp Cell Res. 2019;383(1):111501.
   PubMed Web of Science ®Google Scholar
• Hu YL, Feng Y, Chen YY, et al. SNHG16/miR-605-3p/TRAF6/NF-κB feedback loop regulates hepatocellular carcinoma metastasis. J Cell Mol Med. 2020;24(13):7637–7651.
   PubMed Web of Science ®Google Scholar
• Chen H, Li M, Huang P. LncRNA SNHG16 promotes hepatocellular carcinoma proliferation, migration and invasion by regulating mir-186 expression. J Cancer. 2019;10(15):3571–3581.
   PubMed Web of Science ®Google Scholar
• Lin Q, Zheng H, Xu J, et al. LncRNA SNHG16 aggravates tumorigenesis and development of hepatocellular carcinoma by sponging miR-4500 and targeting STAT3. J Cell Biochem. 2019;120(7):11604-11615.
   Web of Science ®Google Scholar
• Wang L, Sun L, Liu R, et al. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression. J Exp Clin Cancer Res. 2021;40(1):72.
   PubMed Web of Science ®Google Scholar
• Tan S, Zhang M, Shi X, et al. CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression. J Exp Clin Cancer Res. 2021;40(1):85.
   PubMed Web of Science ®Google Scholar
• Jiang S, Zhang Y, Li Q, et al. KIAA1522 promotes the progression of hepatocellular carcinoma via the activation of the wnt/β-catenin signaling pathway. Onco Targets Ther. 2020;13:5657–5668.
   PubMed Web of Science ®Google Scholar
• Chen L, Huang Y, Zhou L, et al. Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma. Biosci Rep. 2019;39(8):8.
   Google Scholar
• Zhang W, Liu K, Liu S, et al. MicroRNA‑744 inhibits migration and invasion of hepatocellular carcinoma cells by targeting SOX12. Oncol Rep. 2018;40(6):3585–3592.
   PubMed Web of Science ®Google Scholar
• Yang X, Qu S, Wang L, et al. PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612. Oncogene. 2018;37(50):6399–6413.
   PubMed Web of Science ®Google Scholar
• Guan Z, Cheng W, Huang D, et al. High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma. Curr Res Transl Med. 2018;66(1):27–32.
   PubMed Web of Science ®Google Scholar
• Wu Q, Liu HO, Liu YD, et al. Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity. J Biol Chem. 2015;290(2):1170–1185.
   PubMed Web of Science ®Google Scholar